TrialRheumatology (Oxford, England)2021

Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trial.

Rene Westhovens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.